Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cisplatin + cyclophosphamide + dexamethasone + etoposide + methotrexate + vincristine
- Development stage
- Unknown
- Lead developer
- Michigan State University
- Modality
- Small Molecules
- Administration
- Intravenous, Oral, Intrathecal
01
Overview
This is a combination chemotherapy regimen consisting of six different anticancer drugs. Each component has a distinct mechanism of action: - Cisplatin: A platinum-based alkylating agent that forms DNA crosslinks, preventing DNA replication and transcription - Cyclophosphamide: An alkylating agent that interferes with DNA replication - Dexamethasone: A corticosteroid that reduces inflammation and suppresses immune response - Etoposide: A topoisomerase II inhibitor that prevents DNA unwinding - Methotrexate: An antimetabolite that inhibits dihydrofolate reductase - Vincristine: A vinca alkaloid that binds to tubulin and disrupts microtubule formation This intensive multi-drug regimen is likely used for aggressive or advanced cancers.
02
Targets
DNADHFR (Dihydrofolate reductase)GR (Glucocorticoid receptor)TOP2A (DNA topoisomerase II)TUBB (Tubulin (alpha and beta subunits))
Beyond the preview
Go deeper on cisplatin + cyclophosphamide + dexamethasone + etoposide + methotrexate + vincristine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cisplatin + cyclophosphamide + dexamethasone + etoposide + methotrexate + vincristine.